ECTACS: ENDOTHELIAL CELL-TARGETED AMATOXIN CONJUGATES FOR IMPROVED THERAPY OF BREAST CANCER

$2,806,509FY2019Defense Health AgencyDOD

Proteogenomics Research Institute For Systems Medicine

Investigators